Instructors
Ravi Kiran Kaja, PHD
Senior Principal Scientist, Complex Generics, Pharmaceutical Science, The United States Pharmacopeia (USP), United States
Dr. Ravi Kiran Kaja, Ph.D., FRSC, is a senior scientific leader with 20+ years of experience in analytical chemistry and pharmaceutical R&D, specializing in sterile and complex drug products. At USP, he leads scientific strategy for complex generics and develops high impact USP–NF standards that strengthen global quality and regulatory frameworks. His expertise spans formulation analytics, E&L, and technology transfer. A collaborative leader and mentor, Dr. Kaja is dedicated to advancing pharmaceutical quality and supporting the next generation of scientists.
Rodrigo Feliciano, PHARMD, PHD
Senior Principal Scientist, Johnson & Johnson Innovative Medicine, Belgium
Rodrigo Feliciano is a Senior Principal Scientist at Johnson & Johnson, Belgium, and an E&L subject matter expert supporting regulatory strategies for complex drug–device combination products. He has 20 years of experience in analytical chemistry, including nine years focused on E&L, with expertise in chromatography and mass spectrometry. He holds a PharmD from the University of Lisbon and a PhD from the University of Wisconsin–Madison, followed by postdoctoral training in Germany. He has authored 33 peer-reviewed publications, is an active member of the ELSIE community, represents Belgium in ISO/TC 194, and is a Fulbright alumnus.
Alicja Sobantka, PHD
Group Director Corporate Material Qualification, Octapharma, Austria
Chemical engineer with PhD (2013) in resource management and water quality; work experience in composite materials, dairy processing, blood plasma- and cell derived therapeutic proteins, and REACH regulation. Managing E&L at Octapharma since 2015.
Wim Van Rossom
Senior Material Safety Expert, Associate Director, UCB BioPharma, Belgium
Wim Van Rossom is Extractables & Leachables (E&L) Expert at UCB, ensuring product quality and patient safety and application of the current legislation. Wim represents the PhRMA consortium as Quality Topic Lead in the ICH Q3E expert working group establishing the ICH guideline for E&L and he is active within the ELSIE (Extractables & Leachables Safety Information Exchange), BioPhorum and PhRMA consortia. Prior to joining UCB, he held a position at J&J where he provided leadership and expertise as E&L Subject Matter Expert and he has been E&L Study Director at Nelson Labs Europe providing him with hands-on experience in setting up E&L studies as well as an excellent insight and understanding of the leaching behavior of materials.
Have an account?
